Sort
17,288 grants matching “multiple sclerosis”
A NOVEL SIGNALING PATHWAY TO PROMOTE OLIGODENDROCYTE MATURATION LEADING TO A NEW TREATMENT FOR MULTIPLE SCLEROSIS
$984,000University Of Connecticut Health Center · · FY2021 · Department of the Army
Telephone Versus Face-to-Face Administration of CBT for Depression
$983,850David Curtis Mohr · Northwestern University At Chicago · R01 · FY2008 · MH
Neural Control Of Gaze
$983,345Lance M Optican · National Eye Institute · ZIA · FY2011 · EY
PRECLINICAL STUDIES OF BRYOSTATIN-1 TO PROMOTE REMYELINATION AND REPAIR IN MULTIPLE SCLEROSIS
$982,500The Johns Hopkins University · · FY2021 · Department of the Army
Biomarkers and Pathogenesis of Multiple Sclerosis: From Mouse to Human
$982,140Dorothy Anne Cross · Washington University · P01 · FY2011 · NS
Evaluation of clinical samples for virus detection for mechanism of CNS disease
$981,187Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
PAAN/MIF NUCLEASE INHIBITION FOR NEUROPROTECTION IN MULTIPLE SCLEROSIS
$980,943The Johns Hopkins University · · FY2022 · Department of the Army
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$980,619Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
ETSense: Adaptive Portable Essential Tremor Monitor
$979,641Dustin Allen Heldman · Great Lakes Neurotechnologies · R44 · FY2012 · AG
Multivariate machine learning analysis of blood-based RNA expression profiles to distinguish relapsing-remitting and progressive forms of multiple sclerosis
$979,138Charles Floyd Spurlock · Decode Health, Inc. · R44 · FY2025 · AI
From therapeutic mechanisms to unraveling the pathophysiology of MS
$979,095Bibiana Bielekova · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS
Molecular Mechanisms of the Blood Brain Barrier Function and Regulation
$979,016Chenghua Gu · Harvard Medical School · R35 · FY2024 · NS
Nervous System Development and Plasticity
$978,800Richard Douglas Fields · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD
GuMI: New In Vitro Platforms to Parse the Human Gut Epithelial-Microbiome-Immune Axis
$978,402Rebecca L Carrier · Northeastern University · R01 · FY2019 · EB
Gene expression in the human brain
$977,828Mark Cookson · National Institute On Aging · ZIA · FY2022 · AG
Preclinical and Early Clinical Development of a Novel Drug for On-Demand Voiding
$976,908Edward Burgard · Dignify Therapeutics, Llc · U44 · FY2025 · NS
T-Cell Vaccine-A Clinical Trail for Progressive MS
$975,900University Of Southern California · R01 · FY2003 · NS
IMMUNOGENETICS OF DEMYELINATION
$975,819Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2000 · NS
Animal Models Of Neuropsychiatric Disorders
$974,415Jacqueline N. Crawley · National Institute Of Mental Health · ZIA · FY2012 · MH
Epidemiology of Aging and Dementia - Autopsy Research
$973,680Lon Ray White · Kuakini Medical Center · R01 · FY2007 · AG
Postmortem Pathology
$973,411David E Kleiner · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE
$972,425Scott T Weiss · Brigham And Women'S Hospital · U01 · FY2015 · HG
A Novel Probiotic for the Treatment of Sjogren's Syndrome
$972,063Gary Fanger · Rise Therapeutics, Llc · SB1 · FY2022 · DE
The Role of B cells in the Origin and Progression of Multiple Sclerosis
$970,715Stephen L Hauser · University Of California, San Francisco · R35 · FY2019 · NS
Commercialization of a Software Platform to Increase the Efficiency of Human Clinical Trials using Patient-Level Machine Learning Models
$969,314David L Ennist · Origent Data Sciences, Inc. · R44 · FY2018 · TR